Purpose <p>In pT1 rectal adenocarcinoma, adverse pathological features guide the indication for radical surgery; however, they are present in only 10–15% of cases. Therefore, in most patients, accurate en bloc local excision with clear margins and precise submucosal invasion assessment is essential for appropriate risk stratification. Beyond absolute depth, a major challenge is the wide interindividual variability in submucosal thickness. The Taulí-pT1 classification, based on the measurement of healthy residual submucosa (hrSB) from the muscularis propria, has been proposed as an objective and reproducible system. This study aimed to validate this classification.</p> Method <p>An interobserver study was conducted on 30 patients with pT1 rectal adenocarcinoma treated by transanal endoscopic surgery. Four pathologists with varying experience levels independently evaluated digitized histological slides, measuring hrSB, total submucosal thickness, and invasion depth. They also classified specimens as sm1, sm2, or sm3. Interobserver agreement was assessed using intraclass correlation coefficients (ICC), and Fleiss’ and Cohen’s kappa indices.</p> Results <p>Excellent interobserver agreement was observed for hrSB (ICC = 0.99; 95% CI: 0.98–0.99), total submucosal thickness (ICC = 0.96; 95% CI: 0.93–0.98), and depth of invasion (ICC = 0.94; 95% CI: 0.9–0.97). The Taulí-pT1 classification demonstrated good agreement (Fleiss’ kappa = 0.71). Identification of the muscularis mucosae showed moderate agreement (kappa = 0.612).</p> Conclusion <p>The Taulí-pT1 classification demonstrates high interobserver reproducibility, even among pathologists with varying levels of experience, supporting its utility as an objective and standardized tool for the assessment of pT1 rectal adenocarcinoma.</p> Clinical trial registration <p>ClinicalTrials.gov Identifier: NCT06218108.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Interobserver agreement of the Taulí-pT1 classification in rectal pT1 adenocarcinoma

  • Cristina Gener-Jorge,
  • Joan Carles Ferreres Piñas,
  • Ana Belén Moreno Garcia,
  • Doris Sofia Melgar Rivera,
  • Alex Casalots,
  • Anna Nonell,
  • Beatriz Espina,
  • Aleidis Caro-Tarragó,
  • Xavier Serra-Aracil

摘要

Purpose

In pT1 rectal adenocarcinoma, adverse pathological features guide the indication for radical surgery; however, they are present in only 10–15% of cases. Therefore, in most patients, accurate en bloc local excision with clear margins and precise submucosal invasion assessment is essential for appropriate risk stratification. Beyond absolute depth, a major challenge is the wide interindividual variability in submucosal thickness. The Taulí-pT1 classification, based on the measurement of healthy residual submucosa (hrSB) from the muscularis propria, has been proposed as an objective and reproducible system. This study aimed to validate this classification.

Method

An interobserver study was conducted on 30 patients with pT1 rectal adenocarcinoma treated by transanal endoscopic surgery. Four pathologists with varying experience levels independently evaluated digitized histological slides, measuring hrSB, total submucosal thickness, and invasion depth. They also classified specimens as sm1, sm2, or sm3. Interobserver agreement was assessed using intraclass correlation coefficients (ICC), and Fleiss’ and Cohen’s kappa indices.

Results

Excellent interobserver agreement was observed for hrSB (ICC = 0.99; 95% CI: 0.98–0.99), total submucosal thickness (ICC = 0.96; 95% CI: 0.93–0.98), and depth of invasion (ICC = 0.94; 95% CI: 0.9–0.97). The Taulí-pT1 classification demonstrated good agreement (Fleiss’ kappa = 0.71). Identification of the muscularis mucosae showed moderate agreement (kappa = 0.612).

Conclusion

The Taulí-pT1 classification demonstrates high interobserver reproducibility, even among pathologists with varying levels of experience, supporting its utility as an objective and standardized tool for the assessment of pT1 rectal adenocarcinoma.

Clinical trial registration

ClinicalTrials.gov Identifier: NCT06218108.